Educational information: This article does not diagnose a condition or replace individualized medical care. Seek urgent or emergency care for concerning symptoms.
AMH is commonly misunderstood
Anti-Müllerian hormone, or AMH, is produced by cells associated with developing ovarian follicles. It is used most meaningfully as part of ovarian-reserve assessment and can help anticipate response to ovarian stimulation in fertility treatment.
It is often sold more broadly as an ‘egg count’ or fertility score. That language overstates what one blood test can establish.
AMH does not measure egg quality
AMH does not directly measure the number of eggs remaining, egg quality, whether the fallopian tubes are open, whether ovulation is occurring normally, uterine factors, endometriosis, sperm health, or whether pregnancy will occur naturally this month—or later.
Age remains a major predictor of reproductive potential. AMH may add context, but it should not replace counseling based on age, history, diagnosis, and reproductive goals.
A low result is not a verdict
A lower AMH result may suggest reduced ovarian reserve or a lower response to stimulation, but it does not prove that natural conception is impossible. ASRM notes that poor ovarian-reserve testing does not necessarily mean an inability to conceive.
A result can be emotionally powerful even when its predictive limits are poorly explained. Before ordering AMH, it is worth asking what decision the result will inform and who will interpret it with you.
A higher result also needs context
Higher AMH can be seen with a greater follicle count and may occur in polyendocrine metabolic ovarian syndrome (PMOS), formerly known as polycystic ovary syndrome (PCOS). However, AMH alone does not diagnose PMOS/PCOS. Cycle history, signs of androgen excess, metabolic context, ultrasound when appropriate, and established diagnostic criteria matter.
Hormonal contraception and other clinical factors can also affect interpretation. A number should never be separated from how and why it was obtained.
Useful fertility testing answers a defined question
AMH may be useful when planning assisted reproduction, evaluating certain reproductive concerns, or interpreting ovarian reserve alongside other findings. Random testing in someone without infertility does not reliably predict short-term natural fertility.
The most responsible approach is not ‘more labs for everyone.’ It is selecting the right information for the person, timing, and decision—then being honest about what remains uncertain.
Common questions
PMOS/PCOS questions patients ask
What does an AMH test measure?
AMH reflects activity from developing ovarian follicles and can contribute to ovarian-reserve assessment. It is especially useful when interpreted for a specific clinical or fertility-treatment decision.
Does a low AMH mean I cannot get pregnant naturally?
No. A lower AMH may suggest reduced ovarian reserve or a lower response to ovarian stimulation, but it does not prove that natural conception is impossible.
Does AMH measure egg quality?
No. AMH does not directly measure egg quality. Age, reproductive history and the broader clinical picture remain important.
Can a high AMH result diagnose PCOS or PMOS?
No. Higher AMH may occur with PMOS/PCOS, but AMH alone does not establish the diagnosis. Cycle patterns, androgen-related findings and other possible causes must be considered.
Where can I get an AMH test interpreted near Navarre?
SANE.Medical in Navarre includes fertility-focused laboratory interpretation within Conceive With Clarity™ so AMH can be considered alongside age, cycles, history, goals and other relevant findings.
One result is not your whole fertility story
Interpret the number in context.
Conceive With Clarity™ connects fertility-focused testing with your age, cycles, medical history, reproductive goals, and the next decision that actually needs to be made.
Explore Conceive With Clarity™ · $697 →Clinical sources
These sources support the general education above. Individual recommendations depend on your history and current guidance.
ASRM: Fertility Evaluation of Infertile Women ↗ACOG: The Use of Antimüllerian Hormone in Women Not Seeking Fertility Care ↗The Lancet: Polyendocrine Metabolic Ovarian Syndrome—the New Name for PCOS ↗
About the author
Dr. Amanda Davis, DNP, FNP-C
Board-certified family nurse practitioner and founder of SANE.Medical, bringing emergency, trauma, forensic, and whole-body clinical perspective into clear, safety-rooted care.
Meet Dr. Davis →